# Study of Inhaler Device Attributes Investigating Critical and Overall Errors, Ease of Use, and Preference Between a Number of Inhaler Devices

> **NCT02184624** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 569 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DEVICE:** ELLIPTA
- **DEVICE:** DISKUS/ACCUHALER
- **DEVICE:** MDI
- **DEVICE:** TURBUHALER
- **DEVICE:** HANDIHALER
- **DEVICE:** BREEZEHALER

## Key facts

- **NCT ID:** NCT02184624
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08-28
- **Primary completion:** 2015-07-31
- **Final completion:** 2015-07-31
- **Target enrollment:** 569 (ACTUAL)
- **Last updated:** 2017-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02184624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02184624, "Study of Inhaler Device Attributes Investigating Critical and Overall Errors, Ease of Use, and Preference Between a Number of Inhaler Devices". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02184624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*